EUVIMEDEUVIMED entdecken
Crossref

Advancements in glycogen detection and spatial profiling reveals a new therapeutic path for Ewing sarcoma

Lyndsay E.A. Young

UKnowledge (University of Kentucky) · 27.01.2023

DOI: 10.13023/etd.2023.027 ↗

Kurz gefasst

Fachartikel in der Zeitschrift UKnowledge (University of Kentucky), erschienen am 27.01.2023. Verfasst von Lyndsay E.A. Young.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Glycogen is the primary glucose storage carbohydrate in mammals, and it is synthesized in most tissues. As glycogen architecture modulates its role in metabolism, it is essential to accurately evaluate and quantify glycogen, glycogen phosphate, and chain length of glucose monomers. Simultaneous quantitation of glycogen architecture is challenging. This work describes a highly-sensitive method for the detection of both glycogen-derived glucose and glucose-phosphate esters utilizing gas-chromatography coupled mass spectrometry (GCMS). We then integrated this glycogen quantitation workflow into a routinely utilized metabolomics-based assay. The work presented describes a workflow for the normalization of polar metabolites utilizing amino acids derived from the insoluble fraction that reduces biological variance and increases detection of small metabolite changes. We extended our mass spectrometry tool kit to include a method to define spatial glycogen architecture in mouse and human tissues using matrix-assisted laser desorption/ionization mass spectrometry imaging (MALDI-MSI). Lastly, we demonstrate that glycogen stores and architecture are heterogeneous among the glycogen accumulating cancers, including the pediatric cancer, Ewing sarcoma. A clinical feature of Ewing sarcoma is the accumulation of Periodic acid-Schiff positive aggregates. Armed with these mass spectrometry techniques, we discovered profound intra-tumoral glycogen accumulation compared to adjacent stroma, normal, muscle, and necrotic tissue. This intra-tumoral glycogen also has an increased phosphate content and distinct chain length profile compared to normal glycogen found in adjacent and patient-matched tissue. Notably, genetic manipulation and pharmacological inhibition of glycogen synthesis, or removal of glycogen phosphates, halted Ewing sarcoma tumor growth in xenografted mouse models. Our work provides insights into glycogen accumulation and uncovers a new therapeutic target for Ewing sarcoma.

Schlagwörter

glycogenEwing sarcomaglycogen accumulationglycogen metabolismtherapeutic targetMALDI mass spectrometry imagingchildhood cancer

Zitieren

APA

Young, L. E. (2023). Advancements in glycogen detection and spatial profiling reveals a new therapeutic path for Ewing sarcoma. UKnowledge (University of Kentucky). https://doi.org/10.13023/etd.2023.027

Vancouver

Young LE. Advancements in glycogen detection and spatial profiling reveals a new therapeutic path for Ewing sarcoma. UKnowledge (University of Kentucky). 2023. doi:10.13023/etd.2023.027

BibTeX
@article{Young2023,
  author = {Young, Lyndsay E.A.},
  title = {Advancements in glycogen detection and spatial profiling reveals a new therapeutic path for Ewing sarcoma},
  journal = {UKnowledge (University of Kentucky)},
  year = {2023},
  doi = {10.13023/etd.2023.027}
}
Kostenlos starten →